Polymorphism of PARP-1 indicates an increased risk and a worse initial severity of ischemic stroke

Per Med. 2018 Sep;15(5):355-360. doi: 10.2217/pme-2018-0007. Epub 2018 Sep 27.

Abstract

Aim: Polymorphisms of DNA repair enzyme gene may alter the ability to repair damage and in turn may contribute to ischemic stroke susceptibility and outcome.

Methods: We selected 316 ischemic stroke patients and 302 healthy controls. Then we genotyped SNPs of PARP-1 rs3219119, rs2271347 and APE1 rs1130409 in patient and control groups.

Results: Polymorphism in PARP-1 rs2271347 was significantly associated with increased ischemic stroke risk (additive model: OR: 1.74; 95% CI: 1.03-2.93; p = 0.037). Patients harboring the PARP-1 rs2271347 GA/AA genotype had a worse initial stroke (additive model: OR: 1.85; 95% CI: 1.10-3.11; p = 0.021).

Conclusion: Our study suggests that genetic variant of rs2271347 may contribute to the etiology of ischemic stroke.

Keywords: DNA repair system; PARP-1; ischemic stroke; polymorphism; prognosis; susceptibility.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alleles
  • Brain Ischemia / genetics*
  • Brain Ischemia / metabolism
  • Case-Control Studies
  • China
  • DNA-(Apurinic or Apyrimidinic Site) Lyase / genetics
  • DNA-(Apurinic or Apyrimidinic Site) Lyase / metabolism
  • Female
  • Gene Frequency / genetics
  • Genetic Predisposition to Disease / genetics
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Poly (ADP-Ribose) Polymerase-1 / genetics*
  • Poly (ADP-Ribose) Polymerase-1 / metabolism
  • Polymorphism, Single Nucleotide
  • Risk Factors
  • Stroke / genetics

Substances

  • PARP1 protein, human
  • Poly (ADP-Ribose) Polymerase-1
  • APEX1 protein, human
  • DNA-(Apurinic or Apyrimidinic Site) Lyase